Julio Triana

Member of the Board of Management — Consumer Health · Bayer

Life Sciences

Julio Triana is president of Bayer’s Consumer Health Division and a member of its Board of Management. He previously held pharmaceutical finance, transformation and commercial leadership roles, following an early career in scientific research and consulting.

Last reviewed: Nov 15, 2026

Executive Summary

Julio Triana is president of Bayer’s Consumer Health Division and a member of its Board of Management. He previously held pharmaceutical finance, transformation and commercial leadership roles, following an early career in scientific research and consulting.

Career Highlights

  • Joined Bayer’s management board in April 2024 and became Consumer Health president the following month.
  • Served as Pharmaceuticals CFO and chief transformation officer.
  • Led commercial operations in Japan and Asia Pacific before taking the International region.

Professional Journey

Triana began his career as a research scientist, moving into consulting at PricewaterhouseCoopers in 1998. His scientific training included a biology bachelor’s degree and chemistry minor at the University of Houston, followed by neuroscience studies at the University of Texas Graduate School of Biomedical Sciences.

He joined Bayer in Colombia in 2002 as head of Corporate Planning & Development. His subsequent finance and operational assignments spanned Latin America, the United States and Europe, taking him through both Consumer Health and Pharmaceuticals. He became chief financial officer of Pharmaceuticals in 2016 and its chief transformation officer in 2020.

In 2021 he was appointed president of Bayer Yakuhin and head of pharmaceutical commercial operations for Japan and Asia Pacific. From 2023 he led the division’s International commercial region while also serving as senior Bayer representative in Japan and president of Bayer Holding there.

Bayer appointed Triana to its Board of Management effective April 1, 2024. He then became president of Consumer Health on May 1, succeeding Heiko Schipper. These were separate transitions: the management-board appointment preceded his assumption of divisional leadership by one month. His business education also includes an MBA from Universidad Antonio de Nebrija in Madrid.

Education

Bachelor of Science, University of Houston — Biology; minor in Chemistry.

Master of Business Administration, Universidad Antonio de Nebrija.